Rate My Professor Felicity Park

Dr Park's research centers on the prediction and prevention of obstetric complications, with a particular emphasis on preterm preeclampsia, fetal growth restriction, aspirin therapy effects on neonates at risk, vaginal progesterone for preterm birth prevention, and cardiovascular health interventions for women with a history of preeclampsia. Her work includes collaborations with Hunter New England Health and the Hunter Medical Research Institute. Notable publications include 'Do first-trimester screening algorithms for preeclampsia aligned to use of preventative therapies reduce the prevalence of pre-term preeclampsia: A systematic review and meta-analysis' (2023), 'Does Aspirin Prescribed to Women Deemed High Risk for Preterm Pre-Eclampsia at 11–13+6 Weeks Gestation Affect the Prevalence of Small for Gestational Age Neonates?' (2021), 'Vaginal progesterone for prevention of preterm birth in asymptomatic high-risk women with a normal cervical length: a systematic review and meta-analysis' (2021), 'Cost effectiveness analysis of a model of first trimester prediction and prevention for preterm preeclampsia against usual care' (2020), 'Be Healthe for Your Heart: A Pilot Randomized Controlled Trial Evaluating a Web-Based Behavioral Intervention to Improve the Cardiovascular Health of Women with a History of Preeclampsia' (2020), and 'Evidence that fetal death is associated with placental aging' (2018). Additionally, she represents the Australian Medical Association for the Hunter region and has been providing outreach ultrasound teaching in the Pacific since 2023, collaborating with the WFUMB Centre of Education in Fiji and the Obstetric Department at Colonial War Memorial Hospital in Suva.